A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid Tumors

This study has been completed.
Sponsor:
Information provided by:
Taiho Pharma USA, Inc.
ClinicalTrials.gov Identifier:
NCT00400023
First received: November 14, 2006
Last updated: April 7, 2011
Last verified: April 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2007
  Primary Completion Date: May 2007 (Final data collection date for primary outcome measure)